CTT Pharmaceutical Holdings, Inc. has disclosed a recent transaction involving its CEO, Ryan Khouri, who acquired 2,000 shares of the company. This transaction, reported in a filing on October 19, 2026, is significant as it demonstrates Khouri's confidence in the company's prospects.
CTT Pharmaceutical Holdings, based in Tampa, Florida, operates within the pharmaceutical preparations sector, classified under SIC code 2834. The company trades on the OTC exchange under the ticker CTTH. CTT has undergone several name changes in the past, previously known as Mindesta Inc., Industrial Minerals Inc., and PNW Capital Inc.
According to the filing, the transaction occurred on October 15, 2026, at a price of $0.057 per share. Following this acquisition, Khouri now owns a total of 9,436,656 shares in the company. The filing notes that this transaction was categorized as an acquisition of shares, indicating a direct ownership stake.
This development may have implications for the company's stakeholders, including investors and employees, as it reflects leadership's belief in the company's direction. The pharmaceutical preparations industry, to which CTT belongs, often sees executives purchasing shares as a sign of confidence, potentially influencing market perceptions.
The filing does not specify any further actions or upcoming events related to this transaction.